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Abstract: Inkjet printing is novel approach in drug manufacturing that enables dispensing precise
volumes of ink onto substrates. Optimal substrate properties including suitable mechanical charac-
teristic are recognized as crucial to achieve desired dosage form performance upon administration.
Identification of relevant quality attributes and their quantification is subject of intensive scientific
research. The aim of this work was to explore applicability of different materials as printing substrates
and explore contribution of the investigated substrate properties to its printability. Substrates were
characterized with regards to uniformity, porosity, disintegration time, mechanical properties and
drug dissolution. Experimentally obtained values were mathematically transformed and the obtained
results were presented as relevant radar charts. It was shown that structurally different substrates
may be employed for orodispersible films inkjet printing. Main disadvantage of single-polymer
films was low drug load, and their printability was dependent on film flexibility and mechanical
strength. Structured orodispersible film templates exhibited favorable mechanical properties and
drug load capacity. Wafer edible sheets were characterized with high mechanical resistance and
brittleness which somewhat diminished printability, but did not hinder high drug load. Obtained
results provide insight into application of different materials as printing substrates and contribute to
understanding of substrate properties which can affect printability.
Keywords: inkjet printing; printing substrates; mechanical properties; orodispersible films; struc-
tured orodispersible film templates; wafer edible sheets
1. Introduction
Inkjet printing (IJP) is a commonly used digital fabrication technique which allows
processing and precise deposition of various liquid materials onto suitable substrates.
It is recognized as a novel promising technology for medicine manufacture providing
patient-centric drug delivery, and individualization of therapy through flexible dosing
of multiple, usually high potency active pharmaceutical ingredients (API) in accordance
with the patient specific needs [1,2]. The principle of IJP is that the ink, which contains
active pharmaceutical ingredient/s, is precisely transferred onto the selected substrate. In
order to obtain targeted drug product profile, both ink formulation, as well as substrate
properties should be carefully considered [3–5].
Iftimi et al. defined the ideal printing substrate as a uniform, edible and flexible
porous open-pore carrier that could be produced in large sheets [6]. They qualitatively sum-
marized specific substrate properties that are needed in order to obtain optimal printing
substrate. The importance of substrate mechanical stability was highlighted as it ensures
printing of high volumes of the API-containing ink. Morphology, water penetration rate,
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low hygroscopicity, porosity, swelling index and fast dissolution were also evaluated as
factors that can affect substrate printability [6]. Mechanically stable substrates enable film
printing, distribution and administration without final dosage form damaging, i.e., they
should be flexible enough, but still resistant enough to ensure maintenance of dosage
form integrity during printing and handling steps [7]. Methodology for printing substrate
mechanical properties evaluation and relevant specifications are subject of intensive inves-
tigation. Visser et al. [8] quantified mechanical properties of polymer films and reported
that tensile strength higher than 2 MPa, elongation at break higher than 10% and Young’s
modulus lower than 430 MPa can be considered as optimal for drug-free films handling,
however, these boundaries should be further evaluated with respect to their applicability
for characterization of polymer films intended for use as printing substrates.
Apart from the mechanical strength which reflects the substrate flexibility/rigidity, it
is recognized that the important characteristic for effective printing onto the thin films is
porous structure which facilitates penetration of the API-containing ink [9]. Furthermore,
printing substrates should be relatively thick as opposed to conventional oral strips to
enable printing of higher drug doses, and prevent disintegration upon contact with the
ink [6]. Thus, the main challenge for orodispersible films printing substrates is to prevent
disintegration, rupturing, tearing or winding during printing, while maintaining rapid
disintegration required for orodispersible dosage forms [10].
The most common substrates used for IJP are orodispersible thin films prepared
using different film-forming polymers. It was shown that API printing onto placebo
orodispersible thin films, may overcome certain limitations related to film casting in
terms of product thickness and content uniformity, the associated dose variation, and
unacceptable material waste [9,11]. It was noted that orodispersible thin films need to be
improved in order to further increase the amount of API absorbed and prevent ink leakage
through backside of the printing substrate [7]. Enhanced film porosity was associated with
better control of ink deposition and the ability to entrap higher amount of inkjet-printed
API inside the matrix, although mechanical properties might be somewhat diminished [10].
Structured orodispersible film templates (SOFTs) have been recently introduced as
highly porous substrates which enable increased drug load without compromising its
mechanical properties. Steiner et al. [12] prepared SOFTs by casting dispersion of hydrox-
ypropyl methyl cellulose in hydroxypropyl cellulose ethanolic solution in order to form a
rougher film surface with open pore structure on the top side enabling API-containing ink
to be filled into the pores, and the closed bottom side to circumvent leakage. Open pore
structure is crucial for ink penetration, as closed pore structure with a continuous film on
its surfaces restricts ink penetration [13].
Apart from the casted substrates such as orodispersible thin films or SOFTs, commer-
cially available edible papers, which are often used in the food industry to decorate baked
goods and other food products, might be, also, used as printing substrates. Wafer edible
sheets and rice papers have been previously used as printing substrates for API-containing
inks due to their porous structure and the ability to absorb relatively high amounts of
liquid [14–17].
The aim of this study was to explore applicability of different orodispersible thin films,
structured orodispersible film templates and wafer edible sheets as printing substrates for
IJP. Additionally, printability of substrates was evaluated with respect to porosity, thickness,
drug load capacity and the ability of orodispersible thin films to withstand mechanical stress
and deformation when passing through printer rollers, expressed as relevant mechanical
properties, including film tensile strength, Young’s modulus, elongation at break and
complex modulus.
2. Materials and Methods
2.1. Materials
Four hydrophilic polymers were investigated as single film-forming agents or polymer
blends for printing substrates preparation: (1) hydroxypropyl cellulose (HPC, Klucel®
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GF, Ashland™, Wilmington, DE, USA), (2) polyethylene glycol–polyvinyl alcohol graft
copolymer (PVA-PEG, Kollicoat® IR, BASF, Ludwigshafen, Germany), (3) maltodextrin
(MDX, Glucidex IT6, Roquette, Lestrem, France) and (4) sodium alginate (SA, Fisher
Scientific, Waltham, MA, USA), as well as three commercially available wafer edible sheets
(Easy Bake, UK, Edible print supplies, Birstall, The United Kingdom). Ink formulation
contained caffeine anhydrous (CAF, Sigma-Aldrich Chemie GmbH, Munich, Germany)
as the selected model drug, dissolved in the 7:3 mixture of ethanol (≥99.8%, Honeywell,
Charlotte, NC, USA) and glycerol, 85% (w/w) (Ph. Eur.).
Simulated salivary fluid pH 6.75 [18] prepared with sodium chloride, potassium
phosphate monobasic, disodium hydrogen phosphate, hydrochloric acid (Sigma-Aldrich
Chemie GmbH, Munich, Germany) and purified water (Ph. Eur.) was used as drug
release media.
2.2. Methods
2.2.1. Printing Substrate Preparation
Single-polymer casting dispersions were prepared by dispersing relevant polymer in
water heated to 50 ◦C (in the case of PVA-PEG, SA and MDX) or 70 ◦C (followed by rapid
cooling, in the case of HPC). Dispersions were stirred on the magnetic stirrer (IKA RCT
standard, Staufen, Germany) until homogenization.
Polymer blend casting dispersions were prepared by dispersing PVA-PEG, SA or
MDX in HPC ethanolic solution followed by continuous stirring on the magnetic stirrer for
one hour.
Prepared dispersions were casted on a unit-dose plexiglas plates as described by
Drašković et al. [19]. The films were left to dry under ambient conditions during 24 h, cut
into pieces of defined size (2.5 by 2.5 cm), packed and stored in a desiccator. Commercial
wafer edible sheets were manually cut into 2.5 by 2.5 cm individual films.
2.2.2. Ink Formulation Preparation
Based on the preliminary studies (data not shown), ethanol:glycerol mixture (7:3) has
been selected as liquid vehicle for inkjet printing. Then, 10 mg/mL of CAF was dissolved
in the solvent mixture. Hydrosoluble food dye containing water, propylene glycol, E 124
and E 122 (Aroma, Krusevac, Serbia) was added in order to facilitate visualization of the
printed patterns. Further details on ink characterization are presented in the Table S1 and
Figure S1 from the Supplementary Material.
2.2.3. Drug Printing
Thermal inkjet printer Canon® IP 1300 (Canon, Tokyo, Japan) was used. Cartridges
were adapted by cutting the top cap, removing the ink sponges and pads and rinsing the
empty cartridges with absolute ethanol and purified water. Rectangular printing pattern
(2.5 by 2.5 cm) was designed in Microsoft® Office Word 2019 (Microsoft Inc., Albuquerque,
NM, USA). In the preliminary study (data not shown), best print quality was obtained
using black cartridge (BC-3e BK) solely, therefore, the selected pattern was painted black.
Printer settings were adjusted to the following option: High print quality/glossy photo
paper/grayscale printing. Printing process consisted of five printing cycles, with 15 min
drying step between each cycle. Plain paper was used as a support for individually casted
substrates in order to accomplish precise printing. Paper was preprinted with designed
pattern and substrates were attached onto paper with an adhesive tape.
2.2.4. Printing Substrate Characterization
Uniformity
Film uniformity was assessed based on the individual films weight, thickness and
printed pattern appearance. Thickness was measured at five positions (four corners and
one central point) using micrometer screw Insize 3203-25 A (Insize, Suzhou, China). Film
weight and thickness are presented as mean values (±SD) of ten replicate measurements.
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Printed pattern appearance was assessed by visual inspection of the uniformity of color and
edges definition, after five printing cycles. Uniformly distributed color without smearing
was considered as acceptable appearance (marked with “+”), while visible splashes of color
indicated poor appearance (which was denoted as “−”). The same marking system was
used to denote printed patterns edges definition.
Porosity
Porosity was determined as a relative weight difference of the investigated samples
following 24 h immersion in the paraffin oil as described by Khorasani et al. [20]. Measure-
ments were performed in triplicate and presented as the mean value (±SD).
Additionally, porosity was investigated using the ImageJ software package 1.51k
(National Institutes of Health, Stapleton, NY, USA). Micrographs obtained by trinocular
microscope (SZM-168-TL, Motic, Barcelona, Spain) were converted to 8-bit images and
the threshold was adjusted to color empty space within the structure, while solid parts
remained black. The software was used to calculate fraction of pores in the investigated
sample. Relationship between the experimentally determined porosity values and those
estimated by image analysis was explored using linear regression analysis.
Image Analysis
Trinocular microscope (SZM-168-TL, Motic, Barcelona, Spain) and scanning electron
microscope-SEM (JEOL, JSM-6390 LV, Akishima, Japan) were used to visualize the drug-
free samples surface morphology. SEM sample preparation included cutting samples into
small pieces and fixing them to the sample holder with double-adhesive carbon tape. After
that, samples were coated with gold alloy on sputter coater (Baltec SCD 005, Baltec, Buffalo
Grove, IL, USA) to improve their conductivity during recording. Smile ShotTM software
was used for obtaining images.
Polarized microscopy (Olympus BX51-P polarized microscope, Olympus, Tokyo,
Japan) was employed to detect presence of CAF crystals in the printed samples. For
polarized light microscopy a Sony DXC-950P digital camera (Sony, Tokyo, Japan) was used
with CellSens Entry 3.1 software (Olympus, Tokyo, Japan).
Disintegration
Disintegration time (DT) of the investigated samples was recorded before and after
five printing cycles. Disintegration test for orodispersible dosage forms developed by
Preis et al. [21] was employed using 500 mL of the simulated salivary fluid heated to
37 ± 0.5 ◦C in the compendia disintegration apparatus (Erweka ZT52, Langen, Germany).
Individual films were fixed with a holder attached to the upper part and the magnet (3 g)
attached to its bottom side. Disintegration endpoint was determined as the time when the
magnet attached to the investigated sample dropped down. Six samples were tested, and
the results are reported as mean value (±SD). Paired t-test was used for comparison of
disintegration time values before and after printing.
Mechanical Properties
Mechanical properties of the investigated printing substrates were evaluated using
the Precision universal tester (Shimadzu AG-X plus, Shimadzu Corporation, Kyoto, Japan).
The test was performed according to the ISO 527-3 regulation [22]. Samples were cut in the
bone shaped specimens, clamped with the film extension grip which moved at a speed of
1 mm/min until sample breakage. The measurements were performed in triplicate. Sample
tensile strength (TS), elongation at break (EB) and Young’s modulus (YM) were calculated
according to the Equations (1)–(3).
TS (MPa) = F/A (1)
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where F is maximal applied load and A cross-sectional area.
EB (%) = 100 × (∆L0)/L0 (2)
where ∆L0 is the extension and L0 is the original length
YM = (σ2 − σ1)/(ε2 − ε1) (3)
where σ2 − σ1 represents the applied stress over strain ε1 and ε2.
Viscoelasticity of the investigated samples was evaluated based on the complex modu-
lus (G*) values determined by oscillatory rheometry (RheometerRheolab MC 120, PaarPhys-
ica, Stuttgart, Germany) using the parallel plate measuring system MP50 (diameter 12.5 mm,
gap 50 µm) with samples placed into frames to prevent drifting.
Oscillatory measurements were performed to determine linear viscoelastic region
of the investigated samples (amplitude sweep). After linear viscoelastic region was de-
termined and all the measurements were performed at the constant strain (1%) within
frequency range 0.1–10.0 Hz to estimate the impact on the change in storage (elastic)
modulus (G′) and loss (viscous) modulus (G”) values.
G* is calculated using the following equation [23]:
|G*|=
√
((G′)2 + (G”)2) (4)
Measurements were performed in triplicate and the results expressed as mean value
(±SD).
Drug Load
Drug load achieved after five printing cycles was determined by dispersing individual
film in 10 mL of purified water on the laboratory shaker (KS 260 basic, IKA VR-Werke
GmbH, Staufen, Germany) at 250 rpm. Obtained samples were filtered through a 0.45 mm
filter (Millipore, Bedford, MA, USA), properly diluted and assayed for CAF at 273 nm using
UV-spectroscopy (UV spectrophotometer EvolutionTM300, Thermo Scientific, Waltham,
MA, USA). Reference measurements were done with drug-free substrates used as a blank
in order to eliminate interference of substrate components. Test was performed in triplicate.
In Vitro Drug Dissolution
CAF dissolution from the printed samples was studied in the small volume dissolution
setup consisting of 100 mL laboratory glasses immersed in the temperature-controlled
shaker (LSB Aqua Pro18, Grant, Shepreth, UK) agitated at 110 rpm. Investigated samples
were attached to the bottom of the glass with the printed side facing up, and 50 mL of
simulated salivary fluid (pH 6.75, 37 ± 0.5 ◦C) was carefully added. Then, 2 mL samples
were withdrawn manually at the pre-determined time intervals. CAF concentration was
determined using UV spectrophotometer (EvolutionTM300, Thermo Scientific, Waltham,
MA, USA) at 273 nm (drug-free substrates were used as blank). The test was performed in
triplicate, and the results are expressed as the mean values (±SD).
Printability Evaluation
Experimentally obtained results for porosity (POR), thickness (TH), EB, TS, YM, G*
and drug load (DL) were mathematically transformed onto the 0–100% scale in order to per-
form comparative evaluation of the investigated substrates printability. Estimated printed
pattern appearance (PPA) was assigned with the value 0, 5 or 10 if the sample scored
none, one or two pluses, respectively. PPA values were, also, transformed onto the 0–100%
scale and value 100% was considered as favorable, as it indicated both the uniformity and
precision of drug distribution. Furthermore, high porosity and substrate thickness were
recognized as factors that contribute to higher drug load [6,12]. Mathematical transfor-
mation of experimentally obtained mechanical characteristics was based on the boundary
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values recommended by Visser et al. [8]. Accordingly, the target value for tensile strength
was set to 2 MPa or higher, while in the case of elongation at break it was equal or higher
than 10%. Young’s modulus was considered more satisfactory in the case of lower values,
while values higher than 400 MPa were unfavorable. Complex modulus might be useful
in prediction of substrates resistance to deformation. Hence, higher values are favorable,
as they can indicate substrates ability to withstand repeated printing cycles [19]. Factors
affecting substrate printability are represented as radar charts which provide multivariate
data visualization, where larger chart area indicates better printability.
3. Results and Discussion
3.1. Printing Substrate Preparation
Ten printing substrate samples were prepared or purchased from the market. Sample
subset I included four polymer films prepared using HPC, PVA-PEG, SA and MDX as
single film-forming agents in the concentration of 7%, except in the case of MDX samples
where, due to film sticking, polymer concentration was set to 5%. The subset II included
three samples prepared as structured orodispersible film templates containing polymer
blends in which HPC was used as binder with the addition of PVA-PEG, SA and/or MDX
as particulate matrix material. The subset III included three wafer edible sheets purchased
from the market. Composition of the investigated samples is presented in Table 1.
Table 1. Sample composition.
Constituents (% w/w) *







S5 7.0 5.0 100.0
S6 7.0 5.0 100.0
S7 7.0 5.0 100.0
III
S8 Corn starch, olive oil, water
S9 Corn starch, olive oil, water
S10 Corn starch, olive oil, maltodextrin, water
* 1% glycerol was added to samples S1–S7; HPC—hydroxypropyl cellulose, PVA-PEG—polyethylene glycol–polyvinyl alcohol graft
copolymer, SA—sodium alginate, MDX—maltodextrine.
3.2. Uniformity
Weight, thickness and the estimated printed pattern appearance of the investigated
samples are presented in Table 2. The subset I samples were characterized with lower
thickness (ranging from 69 to 124 µm), and film weight when compared to the subset II
samples which exhibited higher and more variable thickness (ranging from 309 to 481 µm)
due to the presence of dispersed polymer particles on top of the HPC base which resulted
in rough and uneven film surface. The commercial wafer edible sheets (sample subset III)
also varied in composition and thickness, which ranged from 264 to 502 µm.
Substrate S5 exhibited high level of uniformity with regards to color deposition after
five printing cycles. Occasional splashes of ink were seen on the surface of samples S1,
S7 and S8. Well defined edges of the printed patterns indicate that ink was not smeared
and removed by printer roller. Inconsistency in printed pattern color deposition and edges
definition was observed for substrates S1 and S3, hence they were marked as “poor”.
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Table 2. Printing substrate characteristics.












S1 13.2 ± 1.1 124 ± 5 197.5 ± 0.2 1.3 ± 0.1 2.5 − −
S2 16.2 ± 0.6 121 ± 2 181.5 ± 0.4 1.8 ± 0.2 3.1 + +
S3 13.6 ± 0.4 78 ± 4 54.2 ± 2.6 0.8 ± 0.1 0.5 + −
S4 8.4 ± 0.4 69 ± 4 n/a ** 0.8 ± 0.1 0.3 n/a **
II
S5 31.1 ± 0.7 396 ± 22 437.1 ± 2.5 8.2 ± 0.5 31.8 + +
S6 26.5 ± 0.7 309 ± 12 97.8 ± 4.9 3.0 ± 0.6 9.8 − +
S7 30.9 ± 1.0 481 ± 18 294.2 ± 0.0 6.3 ± 0.5 31.5 − +
III
S8 8.6 ± 0.0 264 ± 6 217.3 ± 4.1 6.9 ± 0.2 33.8 − +
S9 12.4 ± 0.2 369 ± 6 333.2 ± 1.0 9.7 ± 0.2 41.1 + +
S10 18.6 ± 0.2 502 ± 7 151.0 ± 5.6 6.1 ± 0.4 30.4 + +
* mean ± standard deviation; ** n/a—not applicable—sample disintegrated upon contact with ink during printing and *** + acceptable,
− poor.
3.3. Porosity
Experimentally obtained and calculated substrate porosity values are presented in
Table 2. Orodispersible thin films (i.e., subset I) exhibited poor oil absorption capacity and
porosity values were in the range from 0.8 to 1.8%. Porosity values estimated by image
analysis were consistent with the experimentally determined results and ranged from
0.3 to 3.1%. The subset II samples exhibited diverse experimentally determined porosity
values ranging from 3% (which is close to the determined values for orodispersible thin
films) in the case of S6 sample, to more than 6% (which is comparable to wafer edible
sheets) for the samples S5 and S7. Sample S6 contained SA polymer as a particulate matrix
material characterized with good swelling and gelling properties. It can be anticipated that
the reason for a more compact top layer being associated with lower porosity of the SA
containing sample (S6) when compared with samples S5 and S7 containing, respectively,
PVA-PEG and MDX as particulate matrix material might be polymer swelling and gelation
during the film casting and drying, as discussed by Shi et al. [24].
Commercial wafer edible sheets (i.e., the subset III samples) exhibited high porosity
values, ranging from 6.1 to 9.7% as estimated based on the oil absorption capacity, and
30.4 to 41.1% estimated by image analysis. However, linear regression analysis indicated
high correlation between experimentally and ImageJ determined porosity (y = 4.88x – 3.44,
R = 0.98).
3.4. Image Analysis
Photomicrographs of the investigated samples obtained by the trinocular microscope
are presented in Figure 1. While the subset I samples (Figure 1a) reflected the image of
transparent material, without any inner structure, photomicrographs of the subset II and
III samples (Figure 1b,c) showed notable differences with respect to their inner structure
and pore distribution.
Open pores which allow light transition were visible in the samples S5 (HPC-PVA-
PEG SOFT) and S7 (HPC-MDX SOFT), with more uniform pore distribution evident for
the sample S5. Such structure is in accordance with relatively high porosity of these
samples. Sample S6 (HPC-SA SOFT) exhibited compact inner structure without any
transparent sections which is in accordance with low porosity value obtained for this
sample. Commercial wafer edible sheets exhibited uniform distribution of open pores
which is consistent with their high porosity values. In addition, in contrast to the subset II
samples, subset III samples enabled intensive light transition, probably due to the lack of
closed bottom side which is attributed to SOFTs.
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Figure 1. Photomicrographs (50×) of the investigated printing substrates obtained by trinocular microscope: (a) subset I;
(b) subset II and (c) subset III (for the sample composition refer to Table 1).
The cross-sectional structures of the samples were assessed using SEM (Figure 2).
Subset I samples appeared dense with no inner pores, but there were differences in mi-
crostructure. Sample S1 had completely smooth cross-sectional surface while S2 had
wrinkled appearance with higher surface area. S3 had small cracks throughout cross sec-
tional area which might indicate stiff structure. Sample S5 exhibited uniformly distributed
pores and formed wrinkled structure. Sample S6 cross section appeared homogeneous and
similar to orodispersible thin films, which was in agreement with the estimated porosity
values. In the case of sample S7 porous inner structure was observed, but pores were
irregular and sporadically distributed. Similar composition of subset III samples resulted
with similar microstructure with noticeable layers. High porosity might be due to an open
space between layers.
Polarized light photomicrographs of the evaluated printed films are presented in
Figure 3. The obtained photomicrographs provide insight into the presence of needle-
shaped CAF crystals only in the sample S3 (SA) while crystals were not visible in other
investigated samples. Crystallization of CAF at the surface of the S3 substrate might
be associated with the poor drug adhesion onto the printing substrate and incorrect
dosing. It was previously assumed that HPC polymer has the ability to inhibit drug
recrystallization [10], which might explain why CAF crystals were not observed in the
samples containing HPC. Additionally, it was reported that penetration of ink into the
porous printing substrates is associated with altered crystallization behavior compared to
printing on nonporous substrates [25]. Hence, it might be assumed that CAF entrapped
into the porous substrate will not recrystallize. This is in accordance with the absence of
visible CAF crystals in the subset II and III samples.
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Figure 2. SEM Photomicrographs of the investigated substrates: (a) subset I; (b) subset II and (c) subset III.
Figure 3. Photomicrographs of the printed samples obtained using polarized light microscopy (200 µm): (a) subset I;
(b) subset II and (c) subset III.
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3.5. Disintegration
Disintegration times of the drug-free and printed samples are presented in Table 3.
Sample S4, prepared from single-polymer dispersion, ruptured upon first contact with the
ink and was eliminated from further evaluation. Five printing cycles had no significant in-
fluence on disintegration time of the other investigated samples (p = 0.75 for paired samples
t-test). Additionally, all samples fulfilled pharmacopeial requirement for orodispersible
tablets disintegration [26].
Table 3. Investigated samples disintegration before and after five printing cycles.
Disintegration Time
Subsets Samples Before Printing * After Printing *
I
S1 27.0 ± 2.0 26.7 ± 1.0
S2 32.5 ± 0.8 2.2 ± 1.8
S3 41.7 ± 0.9 41.5 ± 2.0
S4 3.5 ± 0.5 n/a **
II
S5 28.2 ± 1.9 28.8 ± 1.6
S6 52.5 ± 1.4 53.1 ± 1.6
S7 46.0 ± 1.3 46.5 ± 2.1
III
S8 17.2 ± 1.2 17.0 ± 0.9
S9 20.8 ± 0.7 20.5 ± 1.0
S10 129.3 ± 2.5 129.3 ± 1.4
* mean ± standard deviation and ** sample disintegrated upon contact with ink during printing.
Although films prepared from polymer blends dispersion (i.e., subset II samples)
were thicker than the single polymer film samples (subset I) this was not associated with
prolonged disintegration. Similar disintegration was observed for S1 and S5, which might
be attributed to higher porosity of the sample S5, in which the open pore side enabled
rapid water penetration. Samples S6 and S7 exhibited somewhat longer disintegration time
possibly due to lower porosity and, consequently, slower water penetration through the
top side of the samples.
The results obtained revealed that S8 and S9 samples, which contain highly porous
structure with both sides open, exhibited shortest disintegration times. On the other hand,
sample S10 exhibited the longest DT. Highly porous structure with both sides open was
associated with very fast disintegration, while multidimensional inner structure and higher
film thickness might be the reason for somewhat different behavior of the sample S10.
3.6. Mechanical Properties
Mechanical properties of the evaluated drug-free samples, including tensile strength,
elongation at break, Young’s modulus and complex modulus are presented in Table 4.
Elongation at break is described as the capacity of film to stretch before it breaks. Therefore,
if the elongation at break is high, sample structure might be considered as flexible and
ductile [27]. The obtained results revealed the highest EB value (272.9%) for the sample S1
which contained hydroxypropyl cellulose as the single film forming polymer. Although
some level of flexibility is required for the substrate to be able to fold when it passes through
the printer, extensive flexibility might cause sample stretching leading to erroneous drug
disposition [28]. On the contrary, low EB determined for samples S3 and wafer edible sheets
(S8–10) indicate potential rupturing during film folding due to pronounced brittleness.
Elongation at break values for samples S5 and S7 were comparable (i.e., around 11%),
while the sample S6 exhibited somewhat higher flexibility. The subset II samples were
characterized with flexible structure, but when compared to S1 substrate it can be assumed
that addition of particulate matrix material greatly reduced film flexibility. The obtained EB
values indicate that the subset II substrates can fold multiple times during printing without
dose disruption. The subset III samples exhibited low EB values which could potentially
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lead to problems during multiple printing cycles, as their lack of flexibility limits folding
without breaking.
Table 4. Mechanical properties of the investigated printing substrates
Subsets Sample EB * (%) TS * (MPa) YM * (MPa) G* (MPa)
I
S1 272.91 ± 0.00 0.43 ± 0.00 2.99 ± 0.00 0.58 ± 0.06
S2 21.14 ± 1.07 8.26 ± 0.36 146.25 ± 0.07 0.73 ± 0.12
S3 2.50 ± 0.37 53.63 ± 6.67 3498.00 ± 173.09 90.35 ± 4.34
II
S5 11.31 ± 1.66 1.52 ± 0.16 182.67 ± 8.95 433.12 ± 15.34
S6 28.77 ± 8.43 1.07 ± 0.13 111.86 ± 13.33 642.98 ± 16.12
S7 11.27 ± 0.52 4.11 ± 0.31 403.67 ± 36.18 467.63 ± 28.98
III
S8 1.86 ± 0.21 3.81 ± 0.66 300.45 ± 0.64 0.35 ± 0.06
S9 1.49 ± 0.31 1.14 ± 0.53 105.49 ± 16.84 2.65 ± 0.07
S10 0.67 ± 0.18 1.66 ± 0.38 290.20 ± 22.77 601.29 ± 0.08
* mean ± standard deviation. EB—elongation at break, TS—tensile strength, YM—Young’s modulus and G*—complex modulus.
Tensile strength is defined as the maximum load force used to break the sample.
Hard and brittle substrates demonstrate very high mechanical resistance [29]. Generally,
somewhat higher TS is preferred in the case of printing substrates in order to avoid tearing
which could result from the constant stress induced by the printing rollers. High flexibility
of the sample S1 was accompanied with lower mechanical resistance compared to the
other subset I samples. Sample S3 containing sodium alginate exhibited extreme brittleness
and the highest strength among all the investigated samples, which might cause certain
problems during repeated printing cycles. Considering that HPC presents the base polymer
in the subset II samples, all substrates exhibited more flexible and less brittle structure
compared to thin orodispersible films. Commercially available, edible sheets (subset III)
exhibited lower TS values, which is in accordance with the literature data reported by
Vakili et al. [16].
Young’s modulus is associated with film stiffness and capacity to undergo elastic
deformation under applied stress [29]. Strong positive correlation between YM and TS
values was established (R2 = 0.98), indicating that more mechanically resistant substrates are
also stiffer. YM, also, represents parameter that can serve as reliable indicator of substrate
durability during printing and further handling. The obtained results revealed great
diversity in YM values in the subset I (i.e., single polymer films) confirming pronounced
impact of polymer characteristics. Sample S1 prepared with HPC exhibited the lowest
(2.99 MPa) while sample S3 prepared with SA exhibited the highest determined YM value
(3498 MPa), which was in accordance with the other investigated mechanical properties.
As it was previously reported, presence of MDX in the sample S7 might be related to the
increased film hardness and stiffness, without affecting film flexibility as discussed by
Cilurzo et al. [30]. According to the presented results, all the investigated samples, except
sample S3, had YM in line with recommendation, i.e., lower than 430 MPa [8].
Complex modulus is defined as a measure of total resistance of the system to strain.
It is noted that systems that have increased fraction of the dispersed phase are character-
ized with higher G* values, as a result of the particle–particle interaction and more rigid
structure [19,31]. Low values of G*, which were determined for samples S1 and S2 indicate
greater flexibility, while the highest complex modulus value observed for S6 might be
related to stiffer and less flexible structure. Although Young’s modulus values of the subset
III samples were comparable, substrate S10 had very high G*, probably due to higher
thickness and more complex inner structure (as presented in Figure 2).
3.7. Drug Load
Determined drug load of the investigated orodispersible films, after five repeated
printing cycles, are presented in Table 2. The obtained results revealed great inconsistency
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of CAF load in the investigated samples, ranging from 54.2 to 437.1 µg. In the subset I
samples, lower amounts of drug were incorporated indicating that thin orodispersible films
could hold ink only on the top of the surface. The only exception was evident in the sample
S3 (prepared with SA), where CAF recrystallization caused facilitated removal of printed
drug during successive printing cycles. Within the subset II, the highest drug content was
incorporated in the sample S5 (437.1 µg), which is in accordance with the highest porosity
and uniform distribution of open pores observed (Figure 2a). Commercially available
edible substrates (subset III) are produced with intention to reach high sorption capacity
for edible inks. It was noticed that level of porosity affects the amount of drug incorporated.
According to the presented results it might be assumed that substrate porosity is the main
indicator of the drug load capacity, so the sample S5 with uniform and high porosity
and the highest drug content incorporated can be considered as favorable among the
presented samples.
3.8. In Vitro Drug Dissolution
The cumulative percentages of CAF released from different orodispersible films as
a function of time are presented in Figure 4. There were no remarkable differences in
dissolution profiles of the investigated samples during the first five minutes. Printed CAF
was predominantly deposited on the surface of orodispersible thin films, thus drug dis-
solved almost immediately upon contact with dissolution media (Figure 4a). Interestingly,
more than 80% of CAF was released within 10 min from all the subset I samples and
subset III samples S8 and S9 indicating that, despite differences in structure, thickness and
porosity, both sides open structure enables, also, fast drug release (Figure 4a,c). Sample S10,
which had the highest thickness, exhibited slightly prolonged CAF release probably due to
the multidimensional structure and longer drug diffusion distance. Drug release profiles
were in rank-order with the determined film disintegration times. Although somewhat
slower CAF dissolution was observed from the subset II, (Figure 4b), more than 80% CAF
was released from all the investigated samples within 30 min. Standard deviation within
triplicate samples was in the range from 0.35 to 6.07%. This implies rather low variability
of data.
3.9. Printability Evaluation
The comprehensive results of the investigated substrate printability evaluation are
presented in Figure 5 as radar charts of the selected performance indicators. Experimentally
determined parameters mathematically transformed, in order to standardize the values
and facilitate printability comparison. The higher radar chart factor values are considered
favorable (0%—not acceptable, 100%—acceptable) and the higher radar chart surface area
indicates better printability. Boundaries suggested by Visser et al. for mechanical properties
correspond to 100% [8]. The highest porosity, thickness and complex modulus values as
well as the highest printed pattern score correspond to 100%. Scores from 0 to 100% were
drawn on radar charts.
Sample S3 was eliminated from printability assessment, due to observed CAF crys-
tallization and excessive brittleness, which was also reflected in the very high Young’s
modulus value. Radar chart for the subset I samples (Figure 5a) revealed that sample
S2 has higher relative surface area (20.4%) compared to sample S1 (6.9%). Mechanical
properties were the main factor that contributed to sample S2 better printability, as these
films were mechanically stronger but, at the same time, flexible enough to endure printing.
The opposite, lower brittleness in conjunction with poor mechanical resistance observed in
the sample S1 negatively affected its printability. The appearance of the printed patterns
was also favorable in the case of S2 sample contributing to its overall performance as the
drug printing substrate.
Within the subset II, sample S5 had notably higher relative surface area (59.2%) in
comparison to samples S6 (26.1%) and S7 (42.1%). As the elongation at break was higher
than 10%, its contribution was equal for all three samples. Tensile strength and Young’s
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modulus values were not critical for printability the of subset II samples, as they exhibited
high flexibility, with appropriate tensile strength and Young’s modulus values. High drug
load and porosity were main discriminative factors. Sample S5 had the highest values
of those two parameters, as well as the favorable printed pattern appearance. It can be
assumed that similarity in structure of samples S5 and S7 contributed to similarity in factors
that affected their printability, while S6 was structurally different and complex modulus
was the main parameter that positively affected its printability.
Figure 4. Dissolution profiles of caffeine (CAF) from the investigated samples: (a) subset I; (b) subset
II and (c) subset III
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Figure 5. Radar charts for printability assessment of the investigated samples: Subset I (a); subset II (b) and
subset III (c). POR—porosity, TH—thickness, DL—drug load and PPA—printed pattern appearance.
Within the subset III, samples S8 and S10 had similar relative surface areas (23.5%
and 23.7%, respectively), although different parameters contributed to their printability.
Sample S9 exhibited slightly higher relative surface area (29.9%) as higher porosity, and
consequently higher drug load, with the good printed pattern appearance which positively
affected its printability. Elongation at break values of the investigated wafer edible sheets
were lower than 10%, so this parameter did not affect the subset III sample printability.
The main difference between S8 and S10 samples printability was higher thickness and
complex modulus for S10. As mentioned previously, high thickness values could indicate
higher drug load, which was not the case with sample S10 as its drug load was not
remarkable higher.
4. Conclusions
The results obtained indicate that different types of printing substrates may be used
for drug inkjet printing. Although single polymer thin films with targeted mechanical
properties could be used as printing substrates, their major disadvantage is low drug
load, since drug deposition is limited to the film surface. Structured orodispersible film
templates provided substantial advantages over the single polymer films with regards
to the amount of drug incorporated. The appropriate combination of particulate matrix
material and base polymer is important to ensure uniform porosity and good mechanical
properties. Wafer edible sheets had comparable drug load to structured orodispersible film
templates, but their mechanical properties were limiting for multiple printing cycles.
Construction of radar charts enabled visualization of relative contribution of each
of the parameters evaluated on the investigated substrates printability and facilitated
their comparative analysis. Differences in substrate structure governed which parameters
predominantly affected their printability. Printability of single-polymer thin films was
mainly dependent on the elongation at break and tensile strength values. Major challenge
is to obtain good balance between flexibility and brittleness in order to avoid excessive
stretching or tearing of thin films. In the case of structured orodispersible film templates
it was evident that porosity was the key contributor to high drug load and more porous
films had overall better printability characteristics. Furthermore, Young’s modulus and
complex modulus must be taken into consideration as porous films can be overly rigid
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which negatively affects their printability due to possible rupture during the printing. Ad-
ditionally, the printed pattern appearance could be useful indicator of substrate printability
and included in printability evaluation. The obtained results provide new insight into the
printing substrate characteristics and can possibly contribute to development of printability
scoring system that could facilitate substate selection and production.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/pharmaceutics13040468/s1, Figure S1: Viscosity flow curve, Table S1: Characteristics of
ethanol, liquid vehicle and ink.
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